Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth

Group 1 - Zai Lab Limited (NASDAQ: ZLAB) has seen its share price increase by over 105% on a 12-month basis and nearly 50% year-to-date [2] - The company markets and sells seven drugs developed by US and European pharmaceutical companies [2] - The investing group Haggerston BioHealth provides insights for both novice and experienced biotech investors, including catalysts, buy and sell ratings, product sales forecasts, and integrated financial statements [2] Group 2 - Edmund Ingham, a biotech consultant with over 5 years of experience, has created detailed reports on more than 1,000 companies in the biotech, healthcare, and pharma sectors [2]